ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Pulmonary hypertension (PH) is a heterogeneous condition. To date, no registry data exists reflecting the spectrum of disease across the five diagnostic groups encountered in a specialist referral centre. Data was retrieved for consecutive, treatment-naïve cases diagnosed between 2001 and 2010 using a catheter-based approach. 1,344 patients were enrolled, with a mean follow-up of 2.9 yrs. The 3-yr survival was 68% for pulmonary arterial hypertension (PAH), 73% for PH associated with left heart disease, 44% for PH associated with lung disease (PH-lung), 71% for chronic thromboembolic PH (CTEPH) and 59% for miscellaneous PH. Compared with PAH, survival was inferior in PH-lung and superior in CTEPH (p<0.05). Multivariate analysis demonstrated that diagnostic group independently predicted survival. Within PAH, Eisenmenger’s survival was superior to idiopathic PAH, which was superior to PAH associated with systemic sclerosis (p<0.005). Within PH-lung, 3-yr survival in sleep disorders/alveolar hypoventilation (90%) was superior to PH-lung with chronic obstructive pulmonary disease (41%) and interstitial lung disease (16%) (p<0.05). In CTEPH, long-term survival was best in patients with surgically accessible disease undergoing pulmonary endarterectomy. In this large registry of consecutive, treatment-naïve patients identified at a specialist PH centre, outcomes and characteristics differed between and within PH groups. The current system of classification of PH has prognostic value even when adjusted for age and disease severity, emphasising the importance of systematic evaluation and precise classification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Authors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Updated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Primary Pulmonary Hypertension: A National Prospective Study
RICH, S., DANTZKER, D. R., AYRES, S. M., BERGOFSKY, E. H., BRUNDAGE, B. H., DETRE, K. M., FISHMAN, A. P., GOLDRING, R. M., GROVES, B. M., KOERNER, S. K., et al. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-216 · Cited by 2,039
Pulmonary Arterial Hypertension in France: Results from a National Registry
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaici, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1668oc · Cited by 2,000
Primary Pulmonary Hypertension
Rubin, L. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360207 · Cited by 1,726
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Benza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Development of a shuttle walking test of disability in patients with chronic airways obstruction.
Singh, S. J., Morgan, M. D., Scott, S., Walters, D., & Hardman, A. E. (1992) · Thorax · doi:10.1136/thx.47.12.1019 · Cited by 1,455
Humbert, M., Sitbon, O., Chaouat, A., Bertocchi, M., Habib, G., Gressin, V., Yaïci, A., Weitzenblum, E., Cordier, J.-F., Chabot, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911818 · Cited by 1,399
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension
Sitbon, O., Humbert, M., Jaïs, X., Ioos, V., Hamid, A. M., Provencher, S., Garcia, G., Parent, F., Hervé, P., & Simonneau, G. (2005) · Circulation · doi:10.1161/circulationaha.104.488486 · Cited by 1,255
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1102.105289 · Cited by 1,184
Pulmonary Arterial Hypertension
Badesch, D. B., Raskob, G. E., Elliott, C. G., Krichman, A. M., Farber, H. W., Frost, A. E., Barst, R. J., Benza, R. L., Liou, T. G., Turner, M., et al. (2010) · Chest · doi:10.1378/chest.09-1140 · Cited by 1,178
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1202.105290 · Cited by 887
(2006) · Encyclopedic Reference of Molecular Pharmacology · doi:10.1007/3-540-29832-0_1355 · Cited by 885
Longterm Follow-up of Patients with Pulmonary Thromboembolism
Riedel, M., Stanek, V., Widimsky, J., & Prerovsky, I. (1982) · Chest · doi:10.1378/chest.81.2.151 · Cited by 830
An epidemiological study of pulmonary arterial hypertension
Peacock, A. J., Murphy, N. F., McMurray, J. J. V., Caballero, L., & Stewart, S. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092306 · Cited by 792
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension
Humbert, M., Sitbon, O., Yaïci, A., Montani, D., O'Callaghan, D. S., Jaïs, X., Parent, F., Savale, L., Natali, D., Günther, S., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00057010 · Cited by 674
Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era
Condliffe, R., Kiely, D. G., Peacock, A. J., Corris, P. A., Gibbs, J. S. R., Vrapi, F., Das, C., Elliot, C. A., Johnson, M., DeSoyza, J., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200806-953oc · Cited by 657
Self-citationPulmonary hypertension in COPD
Chaouat, A., Naeije, R., & Weitzenblum, E. (2008) · European Respiratory Journal · doi:10.1183/09031936.00015608 · Cited by 625
Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation
Thenappan, T., Shah, S. J., Rich, S., Tian, L., Archer, S. L., & Gomberg-Maitland, M. (2010) · European Respiratory Journal · doi:10.1183/09031936.00072709 · Cited by 493
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Cottin, V., Le Pavec, J., Prévot, G., Mal, H., Humbert, M., Simonneau, G., Cordier, J.-F., & GERM“O”P (2010) · European Respiratory Journal · doi:10.1183/09031936.00038709 · Cited by 478
A USA-based registry for pulmonary arterial hypertension: 1982–2006
Thenappan, T., Shah, S. J., Rich, S., & Gomberg-Maitland, M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00042107 · Cited by 432
Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL
Chung, L., Liu, J., Parsons, L., Hassoun, P. M., McGoon, M., Badesch, D. B., Miller, D. P., Nicolls, M. R., & Zamanian, R. T. (2010) · Chest · doi:10.1378/chest.10-0260 · Cited by 431
Kawut, S. M., Taichman, D. B., Archer-Chicko, C. L., Palevsky, H. I., & Kimmel, S. E. (2003) · Chest · doi:10.1378/chest.123.2.344 · Cited by 427
Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension
Condliffe, R., Kiely, D. G., Gibbs, J. S. R., Corris, P. A., Peacock, A. J., Jenkins, D. P., Hodgkins, D., Goldsmith, K., Hughes, R. J., Sheares, K., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1841oc · Cited by 400
Self-citationJais, X., Launay, D., Yaici, A., Le Pavec, J., Tchérakian, C., Sitbon, O., Simonneau, G., & Humbert, M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23303 · Cited by 398
Dimopoulos, K., Inuzuka, R., Goletto, S., Giannakoulas, G., Swan, L., Wort, S. J., & Gatzoulis, M. A. (2010) · Circulation · doi:10.1161/circulationaha.109.883876 · Cited by 388
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
Montani, D., Savale, L., Natali, D., Jais, X., Herve, P., Garcia, G., Humbert, M., Simonneau, G., & Sitbon, O. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq170 · Cited by 362
Clinical differences between idiopathic and scleroderma‐related pulmonary hypertension
Fisher, M. R., Mathai, S. C., Champion, H. C., Girgis, R. E., Housten‐Harris, T., Hummers, L., Krishnan, J. A., Wigley, F., & Hassoun, P. M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22069 · Cited by 349
Long-Term Outcome after Pulmonary Thromboendarterectomy
ARCHIBALD, C. J., AUGER, W. R., FEDULLO, P. F., CHANNICK, R. N., KERR, K. M., JAMIESON, S. W., KAPELANSKI, D. P., WATT, C. N., & MOSER, K. M. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9808109 · Cited by 315
Authors/Task Force Members:, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr046 · Cited by 314
Thenappan, T., Shah, S. J., Gomberg-Maitland, M., Collander, B., Vallakati, A., Shroff, P., & Rich, S. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.110.958801 · Cited by 289 · cited 1×
“This observation has recently been described elsewhere[47]; however we were also able to define long term survival in this patient group.”
BackgroundNew predictors of outcome in idiopathic pulmonary arterial hypertension
Kawut, S. M., Horn, E. M., Berekashvili, K. K., Garofano, R. P., Goldsmith, R. L., Widlitz, A. C., Rosenzweig, E. B., Kerstein, D., & Barst, R. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.006 · Cited by 245
Pulmonary hypertension in a lupus clinic: experience with twenty-four patients.
Asherson, R. A., Higenbottam, T., Dinh‐Xuan, A. T., Khamashta, M. A., & Hughes, G. R. V. (1990) · PubMed · Cited by 210
Meune, C., Avouac, J., Wahbi, K., Cabanes, L., Wipff, J., Mouthon, L., Guillevin, L., Kahan, A., & Allanore, Y. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23463 · Cited by 197
Launay, D., Hachulla, E., Hatron, P.-Y., Jais, X., Simonneau, G., & Humbert, M. (2007) · Medicine · doi:10.1097/md.0b013e3181579781 · Cited by 186
Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy
Overbeek, M. J., Vonk, M. C., Boonstra, A., Voskuyl, A. E., Vonk-Noordegraaf, A., Smit, E. F., Dijkmans, B. A. C., Postmus, P. E., Mooi, W. J., Heijdra, Y., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00106008 · Cited by 184
Galie, N., Palazzini, M., & Manes, A. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq152 · Cited by 175
de Groote, P., Gressin, V, Hachulla, E., Carpentier, P., Guillevin, L., Kahan, A., Cabane, J., Francès, C., Lamblin, N., Diot, E., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.057760 · Cited by 159
Tanaka, E., Harigai, M., Tanaka, M., Kawaguchi, Y., Hara, M., & Kamatani, N. (2002) · PubMed · Cited by 128
Dawson, J., Goodson, N. G., Graham, D. R., & Lynch, M. P. (2000) · British journal of rheumatology · doi:10.1093/rheumatology/39.12.1320 · Cited by 122
Launay, D., Mouthon, L., HACHULLA, E., Pagnoux, C., de Groote, P., Rémy‐Jardin, M., Matran, R., Lambert, M., Queyrel, V., Morell‐Dubois, S., et al. (2007) · PubMed · Cited by 121
Coghlan, G., Corris, P. A., Gaine, S., Gatzoulis, M. Α., Gibbs, J. S. R., Haworth, S. G., Kiely, D. G., Peacock, A. J., Pepke‐Żaba, J., Elliot, C. A., et al. (2008) · Cited by 99
Self-citationLong-term outcome with intravenous iloprost in pulmonary arterial hypertension
Hoeper, M. M., Gall, H. J., Seyfarth, H.-J., Halank, M., Ghofrani, H. A., Winkler, J., Golpon, H. A., Olsson, K. M., Nickel, N. P., Opitz, C. F., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00130408 · Cited by 93
Pulmonary Hypertension in Polymyositis
Bunch, T. W., Tancredi, R. G., & Lie, J. T. (1981) · CHEST Journal · doi:10.1378/chest.79.1.105 · Cited by 79
Novel strategies in diastolic heart failure
Paulus, W. J. (2010) · Heart · doi:10.1136/hrt.2009.169052 · Cited by 21
Cited by
Definitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
Self-citationKonstam, M. A., Kiernan, M. S., Bernstein, D., Bozkurt, B., Jacob, M., Kapur, N. K., Kociol, R. D., Lewis, E. F., Mehra, M. R., Pagani, F. D., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000560 · Cited by 945
Predicting Survival in Patients With Pulmonary Arterial Hypertension
Benza, R. L., Gomberg-Maitland, M., Elliott, C. G., Farber, H. W., Foreman, A. J., Frost, A. E., McGoon, M. D., Pasta, D. J., Selej, M., Burger, C. D., et al. (2019) · Chest · doi:10.1016/j.chest.2019.02.004 · Cited by 643
“Patients with connective tissue diseaseassociated PAH have markedly lower 1-year survival rates than patients with other etiologies.(35,36) Similarly, compared with patients with idiopathic PAH, those with”
BackgroundPulmonary Arterial Hypertension
McGoon, M. D., Benza, R. L., Escribano-Subias, P., Jiang, X., Miller, D. P., Peacock, A. J., Pepke-Zaba, J., Pulido, T., Rich, S., Rosenkranz, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.023 · Cited by 524
The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups
Gall, H., Felix, J. F., Schneck, F. K., Milger, K., Sommer, N., Voswinckel, R., Franco, O. H., Hofman, A., Schermuly, R. T., Weissmann, N., et al. (2017) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2017.02.016 · Cited by 313
Metadata
- Authors
- Hurdman, J., Condliffe, R., Elliot, C. A., Davies, C., Hill, C., Wild, J. M., Capener, D., Sephton, P., Hamilton, N., Armstrong, I. J., Billings, C., Lawrie, A., Sabroe, I., Akil, M., O’Toole, L., & Kiely, D. G.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2011-09-01
- Volume
- 39
- Issue
- 4
- Pages
- 945-955
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2136245768
- Cited by
- 459
- References
- 50
- FWCI
- 13.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.